Excision BioTherapeutics
PrivateLast Round
Grant
Sep 29, 2022
Total Funding Raised
$76.85M
Company Overview
Excision BioTherapeutics is a biotechnology company developing CRISPR-based gene editing therapeutics to cure viral infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Excision BioTherapeutics Comparables
Compare Excision BioTherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| American Gene Technologies | 84% | |
| Shanghai Bendao Gene Technology | 77% | |
| Intellia Therapeutics | 75% |
Excision BioTherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 29, 2022 | ||||
| Series A | Feb 17, 2021 | ||||
| Seed | Sep 6, 2017 |
Excision BioTherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GreatPoint Ventures | Series A |
| Cota Capital | Series A |
| Gaingels | Series A |
| GreatPoint Ventures | Series A |
| WRVI Capital | Series A |
| ARTIS Ventures | Series A, Seed |
| Bioverge | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 17, 2025
Presented data at the ICE-HBV Hepatitis B Cure Symposium.
- Sep 17, 2025
EBT-107 program shows safety and potency for hepatitis B treatment.
Excision BioTherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Excision BioTherapeutics's valuation, stock price, and market status.
Is Excision a public or private company?
Excision is a private company.
What is the current stock price of Excision?
Excision is a private company with no public stock price. No recent secondary market data is available.
How much is Excision worth (valuation)?
Valuation information for Excision is not publicly available.
Can I buy Excision stock?
Excision shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Excision's last funding round?
Excision's most recent funding round was Convertible Debt on February 17, 2021.
Who are the main investors in Excision?
Key investors in Excision include GreatPoint Ventures, GreatPoint Ventures, WRVI Capital, ARTIS Ventures.
Will Excision IPO soon?
No public IPO plans have been announced for Excision.
How can I track Excision secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Excision's secondary market activity and sign up for updates.